Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 155.71 USD -0.13%
Market Cap: 375.2B USD
Have any thoughts about
Johnson & Johnson?
Write Note

Intrinsic Value

The intrinsic value of one JNJ stock under the Base Case scenario is 163 USD. Compared to the current market price of 155.71 USD, Johnson & Johnson is Undervalued by 4%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

JNJ Intrinsic Value
163 USD
Undervaluation 4%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Johnson & Johnson

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
JNJ
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for JNJ cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...

Fundamental Analysis

Johnson & Johnson
NYSE:JNJ
US
Pharmaceuticals
Market Cap
374.6B USD
IPO
Sep 25, 1944
US
Pharmaceuticals
Market Cap
374.6B USD
IPO
Sep 25, 1944
Price
$
$
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Continued legal challenges, especially around talc-based products and opioid-related lawsuits, could result in substantial settlement costs and negatively impact Johnson & Johnson’s reputation and cash flow.

The recent consumer health spinoff (Kenvue) could dilute brand synergies and disrupt revenue diversification, hindering Johnson & Johnson’s ability to leverage cross-segment strengths in marketing and R&D.

Potential patent expirations in the pharmaceutical segment and intensifying generic competition may reduce pricing power, forcing Johnson & Johnson to allocate additional resources to pipeline development and acquisitions.

Bull Theses

Its diversified portfolio across pharmaceuticals, medical devices, and consumer health products insulates Johnson & Johnson from downturns in any single category, supporting stable revenue and cash generation.

Robust late-stage pharmaceutical pipeline, particularly in oncology and immunology, could secure new growth avenues and help counterbalance upcoming patent expirations.

The spinoff of Kenvue may allow Johnson & Johnson to focus on higher-margin segments, such as medical devices and pharmaceuticals, improving profitability and operational efficiency over the long term.

Show More Less
How do you feel about JNJ?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Johnson & Johnson

Provide an overview of the primary business activities
of Johnson & Johnson.

What unique competitive advantages
does Johnson & Johnson hold over its rivals?

What risks and challenges
does Johnson & Johnson face in the near future?

Has there been any significant insider trading activity
in Johnson & Johnson recently?

Summarize the latest earnings call
of Johnson & Johnson.

What significant events have occurred
in Johnson & Johnson over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Johnson & Johnson.

Provide P/S
for Johnson & Johnson.

Provide P/E
for Johnson & Johnson.

Provide P/OCF
for Johnson & Johnson.

Provide P/FCFE
for Johnson & Johnson.

Provide P/B
for Johnson & Johnson.

Provide EV/S
for Johnson & Johnson.

Provide EV/GP
for Johnson & Johnson.

Provide EV/EBITDA
for Johnson & Johnson.

Provide EV/EBIT
for Johnson & Johnson.

Provide EV/OCF
for Johnson & Johnson.

Provide EV/FCFF
for Johnson & Johnson.

Provide EV/IC
for Johnson & Johnson.

Show me price targets
for Johnson & Johnson made by professional analysts.

What are the Revenue projections
for Johnson & Johnson?

How accurate were the past Revenue estimates
for Johnson & Johnson?

What are the Net Income projections
for Johnson & Johnson?

How accurate were the past Net Income estimates
for Johnson & Johnson?

What are the EPS projections
for Johnson & Johnson?

How accurate were the past EPS estimates
for Johnson & Johnson?

What are the EBIT projections
for Johnson & Johnson?

How accurate were the past EBIT estimates
for Johnson & Johnson?

Compare the revenue forecasts
for Johnson & Johnson with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Johnson & Johnson and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Johnson & Johnson against its competitors.

Analyze the profit margins
(gross, operating, and net) of Johnson & Johnson compared to its peers.

Compare the P/E ratios
of Johnson & Johnson against its peers.

Discuss the investment returns and shareholder value creation
comparing Johnson & Johnson with its peers.

Analyze the financial leverage
of Johnson & Johnson compared to its main competitors.

Show all profitability ratios
for Johnson & Johnson.

Provide ROE
for Johnson & Johnson.

Provide ROA
for Johnson & Johnson.

Provide ROIC
for Johnson & Johnson.

Provide ROCE
for Johnson & Johnson.

Provide Gross Margin
for Johnson & Johnson.

Provide Operating Margin
for Johnson & Johnson.

Provide Net Margin
for Johnson & Johnson.

Provide FCF Margin
for Johnson & Johnson.

Show all solvency ratios
for Johnson & Johnson.

Provide D/E Ratio
for Johnson & Johnson.

Provide D/A Ratio
for Johnson & Johnson.

Provide Interest Coverage Ratio
for Johnson & Johnson.

Provide Altman Z-Score Ratio
for Johnson & Johnson.

Provide Quick Ratio
for Johnson & Johnson.

Provide Current Ratio
for Johnson & Johnson.

Provide Cash Ratio
for Johnson & Johnson.

What is the historical Revenue growth
over the last 5 years for Johnson & Johnson?

What is the historical Net Income growth
over the last 5 years for Johnson & Johnson?

What is the current Free Cash Flow
of Johnson & Johnson?

Discuss the annual earnings per share (EPS)
trend over the past five years for Johnson & Johnson.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Johnson & Johnson

Current Assets 71.6B
Cash & Short-Term Investments 38.8B
Receivables 16B
Other Current Assets 16.8B
Non-Current Assets 122.1B
Long-Term Investments 773m
PP&E 20.9B
Intangibles 81.2B
Other Non-Current Assets 19.3B
Current Liabilities 56.9B
Accounts Payable 9.5B
Accrued Liabilities 29.2B
Short-Term Debt 10.9B
Other Current Liabilities 7.2B
Non-Current Liabilities 58.7B
Long-Term Debt 38.4B
Other Non-Current Liabilities 20.3B
Efficiency

Free Cash Flow Analysis
Johnson & Johnson

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Johnson & Johnson

Revenue
89.3B USD
Cost of Revenue
-28.3B USD
Gross Profit
61.1B USD
Operating Expenses
-37.7B USD
Operating Income
23.4B USD
Other Expenses
-1.6B USD
Net Income
21.8B USD
Fundamental Scores

JNJ Profitability Score
Profitability Due Diligence

Johnson & Johnson's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive Operating Income
68/100
Profitability
Score

Johnson & Johnson's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

JNJ Solvency Score
Solvency Due Diligence

Johnson & Johnson's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
61/100
Solvency
Score

Johnson & Johnson's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

JNJ Price Targets Summary
Johnson & Johnson

Wall Street analysts forecast JNJ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JNJ is 174.05 USD with a low forecast of 151.5 USD and a high forecast of 194.25 USD.

Lowest
Price Target
151.5 USD
3% Downside
Average
Price Target
174.05 USD
12% Upside
Highest
Price Target
194.25 USD
25% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Apr 30, 2025
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for JNJ is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

JNJ Insider Trading
Buy and sell transactions by insiders

JNJ News

Other Videos
What is the Intrinsic Value of one JNJ stock?

The intrinsic value of one JNJ stock under the Base Case scenario is 163 USD.

Is JNJ stock undervalued or overvalued?

Compared to the current market price of 155.71 USD, Johnson & Johnson is Undervalued by 4%.

Back to Top